Quantitative structural analysis of the myocardium during physiologic growth and induced cardiac hypertrophy: a review

The quantitative structural properties of the ventricular myocardium during postnatal physiologic growth are compared with those accompanying an increased load in the adult rat heart to determine whether induced cardiac hypertrophy is a pathologic condition or simply a form of well compensated accelerated growth. The expansion of the ventricular myocardium during maturation shows a remarkable degree of well balanced compensatory response, because the capillary microvasculature, parenchymal cells and subcellular components of myocytes all grow in proportion to the increase in cardiac mass. In contrast, the increases in myocyte diameter and length caused by pressure hypertrophy, volume hypertrophy and infarction-induced hypertrophy are consistent with concentric, eccentric and a combination of concentric and eccentric hypertrophic growth of the whole ventricle, respectively. These cellular shape changes may represent a compensatory response of the myocardium at the cellular level of organization that tends to minimize the effects of an increased pressure or volume load, or both, on the heart. Cardiac hypertrophy, however, may also show alterations affecting capillary luminal volume and surface and the mitochondrial to myofibril volume ratio, which indicate an inadequate growth adaptation of the component structures responsible for tissue oxygenation and energy production. Thus, hypertrophy of the adult heart differs from that during physiologic growth, and the hypertrophied myocardium may exhibit structural abnormalities that can be expected to increase its vulnerability to ischemia.

This article has been cited by other articles:

				S. G. Haworth The cell and molecular biology of right ventricular dysfunction in pulmonary hypertension Eur. Heart J. Suppl., December 1, 2007; 9(suppl_H): H10 - H16. [Abstract] [Full Text] [PDF]

				B. D. Westenbrink, E. Lipsic, P. van der Meer, P. van der Harst, H. Oeseburg, G. J. Du Marchie Sarvaas, J. Koster, A. A. Voors, D. J. van Veldhuisen, W. H. van Gilst, et al. Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization Eur. Heart J., August 2, 2007; 28(16): 2018 - 2027. [Abstract] [Full Text] [PDF]

				M. C.D. Abduch, R. S. Assad, M. Q. Rodriguez, A. S. Valente, J. L. Andrade, L. M.M. Demarchi, M. B. Marcial, and V. D. Aiello Reversible pulmonary trunk banding III: Assessment of myocardial adaptive mechanisms--contribution of cell proliferation J. Thorac. Cardiovasc. Surg., June 1, 2007; 133(6): 1510 - 1516. [Abstract] [Full Text] [PDF]

				H.-J. Li, H. Yin, Y.-Y. Yao, B. Shen, M. Bader, L. Chao, and J. Chao Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3{beta} activation Cardiovasc Res, January 1, 2007; 73(1): 130 - 142. [Abstract] [Full Text] [PDF]

				A. Leri, J. Kajstura, and P. Anversa Cardiac Stem Cells and Mechanisms of Myocardial Regeneration Physiol Rev, October 1, 2005; 85(4): 1373 - 1416. [Abstract] [Full Text] [PDF]

				T. M. Casey, P. G. Arthur, and M. A. Bogoyevitch Proteomic Analysis Reveals Different Protein Changes during Endothelin-1- or Leukemic Inhibitory Factor-induced Hypertrophy of Cardiomyocytes in Vitro Mol. Cell. Proteomics, May 1, 2005; 4(5): 651 - 661. [Abstract] [Full Text] [PDF]

				J. W. Holmes Candidate mechanical stimuli for hypertrophy during volume overload J Appl Physiol, October 1, 2004; 97(4): 1453 - 1460. [Abstract] [Full Text] [PDF]

				V. Jayasankar, Y. J. Woo, L. T. Bish, T. J. Pirolli, M. F. Berry, J. Burdick, R. C. Bhalla, R. V. Sharma, T. J. Gardner, and H. L. Sweeney Inhibition of Matrix Metalloproteinase Activity by TIMP-1 Gene Transfer Effectively Treats Ischemic Cardiomyopathy Circulation, September 14, 2004; 110(11_suppl_1): II-180 - II-186. [Abstract] [Full Text] [PDF]

				Z. A. McCrossan, R. Billeter, and E. White Transmural changes in size, contractile and electrical properties of SHR left ventricular myocytes during compensated hypertrophy Cardiovasc Res, August 1, 2004; 63(2): 283 - 292. [Abstract] [Full Text] [PDF]

				A. F. Corno, G. Milano, S. Morel, P. Tozzi, C. Y. Genton, M. Samaja, and L. K. von Segesser Hypoxia: Unique myocardial morphology? J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1301 - 1308. [Abstract] [Full Text] [PDF]

				C. E. Miller, C. L. Wong, and D. Sedmera Pressure overload alters stress-strain properties of the developing chick heart Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1849 - H1856. [Abstract] [Full Text] [PDF]

				A. Gonzalez, M. A Fortuno, R. Querejeta, S. Ravassa, B. Lopez, N. Lopez, and J. Diez Cardiomyocyte apoptosis in hypertensive cardiomyopathy Cardiovasc Res, September 1, 2003; 59(3): 549 - 562. [Abstract] [Full Text] [PDF]

				G. M. Diffee and D. F. Nagle Regional differences in effects of exercise training on contractile and biochemical properties of rat cardiac myocytes J Appl Physiol, July 1, 2003; 95(1): 35 - 42. [Abstract] [Full Text] [PDF]

				S. Chatterjee, L. T. Bish, V. Jayasankar, A. S. Stewart, Y. J. Woo, M. T. Crow, T. J. Gardner, and H. L. Sweeney Blocking the development of postischemic cardiomyopathy with viral gene transfer of the apoptosis repressor with caspase recruitment domain J. Thorac. Cardiovasc. Surg., June 1, 2003; 125(6): 1461 - 1469. [Abstract] [Full Text] [PDF]

				M. A. Fortuno, A. Gonzalez, S. Ravassa, B. Lopez, and J. Diez Clinical implications of apoptosis in hypertensive heart disease Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1495 - H1506. [Full Text] [PDF]

				F. A Babiker, L. J De Windt, M. van Eickels, C. Grohe, R. Meyer, and P. A Doevendans Estrogenic hormone action in the heart: regulatory network and function Cardiovasc Res, February 15, 2002; 53(3): 709 - 719. [Abstract] [Full Text] [PDF]

				A. Calderone, R. J. L. Murphy, J. Lavoie, F. Colombo, and L. Beliveau TGF-{beta}1 and prepro-ANP mRNAs are differentially regulated in exercise-induced cardiac hypertrophy J Appl Physiol, August 1, 2001; 91(2): 771 - 776. [Abstract] [Full Text] [PDF]

				A. Natali, D. Turner, S. Harrison, and E White Regional effects of voluntary exercise on cell size and contraction-frequency responses in rat cardiac myocytes J. Exp. Biol., January 3, 2001; 204(6): 1191 - 1199. [Abstract] [PDF]

				T. Masuyama, K. Yamamoto, Y. Sakata, R. Doi, N. Nishikawa, H. Kondo, K. Ono, T. Kuzuya, M. Sugawara, and M. Hori Evolving changes in Doppler mitral flow velocity pattern in rats with hypertensive hypertrophy J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2333 - 2338. [Abstract] [Full Text] [PDF]

				G.Y.H Lip, D.C Felmeden, F.L Li-Saw-Hee, and D.G Beevers Hypertensive heart disease. A complex syndrome or a hypertensive 'cardiomyopathy'? Eur. Heart J., October 2, 2000; 21(20): 1653 - 1665. [PDF]

				K. AMANN, K. MÜNTER, S. WESSELS, J. WAGNER, V. BALAJEW, S. HERGENRÖDER, G. MALL, and E. RITZ Endothelin A Receptor Blockade Prevents Capillary/Myocyte Mismatch in the Heart of Uremic Animals J. Am. Soc. Nephrol., September 1, 2000; 11(9): 1702 - 1711. [Abstract] [Full Text]

				R. S. Assad, M. Cardarelli, M. C. Abduch, V. D. Aiello, M. Maizato, M. Barbero-Marcial, and A. Jatene Reversible pulmonary trunk banding with a balloon catheterAssessment of rapid pulmonary ventricular hypertrophy J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 66 - 72. [Abstract] [Full Text] [PDF]

				G. Olivetti, E. Cigola, R. Maestri, C. Lagrasta, D. Corradi, and F. Quaini Recent advances in cardiac hypertrophy Cardiovasc Res, January 1, 2000; 45(1): 68 - 75. [Full Text] [PDF]

				R. L. Skolnick, S. E. Litwin, W. H. Barry, and K. W. Spitzer Effect of ANG II on pHi, [Ca2+]i, and contraction in rabbit ventricular myocytes from infarcted hearts Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1788 - H1797. [Abstract] [Full Text] [PDF]

				S. M. Jorgensen, O. Demirkaya, and E. L. Ritman Three-dimensional imaging of vasculature and parenchyma in intact rodent organs with X-ray micro-CT Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H1103 - H1114. [Abstract] [Full Text] [PDF]

				P. Anversa and J. Kajstura Ventricular Myocytes Are Not Terminally Differentiated in the Adult Mammalian Heart Circ. Res., July 13, 1998; 83(1): 1 - 14. [Full Text] [PDF]

				M. Nanna, L. E. Shapiro, R. Sievert, L. Ong, E. L. Ocampo, R. A. Chance, M. Lee, M. Nanna, K. Ferrick, and M. I. Surks Minimal Cardiac Effects in Asymptomatic Athyreotic Patients Chronically Treated with Thyrotropin-suppressive Doses of L-Thyroxine--Authors' Response J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2607a - 2608. [Full Text]

				M. Kozakova, C. Palombo, L. Pratali, G. Pittella, F. Galetta, and A. L'Abbate Mechanisms of Coronary Flow Reserve Impairment in Human Hypertension: An Integrated Approach by Transthoracic and Transesophageal Echocardiography Hypertension, February 1, 1997; 29(2): 551 - 559. [Abstract] [Full Text]

				K. C. Wollert, T. Taga, M. Saito, M. Narazaki, T. Kishimoto, C. C. Glembotski, A. B. Vernallis, J. K. Heath, D. Pennica, W. I. Wood, et al. Cardiotrophin-1 Activates a Distinct Form of Cardiac Muscle Cell Hypertrophy J. Biol. Chem., April 19, 1996; 271(16): 9535 - 9545. [Abstract] [Full Text] [PDF]

				S. Yamamoto, T. N. James, K.-i. Sawada, M. Okabe, and K. Kawamura Generation of New Intercellular Junctions Between Cardiocytes : A Possible Mechanism Compensating for Mechanical Overload in the Hypertrophied Human Adult Myocardium Circ. Res., March 1, 1996; 78(3): 362 - 370. [Abstract] [Full Text]

				A. Calderone, N. Takahashi, N. J. Izzo Jr, C. M. Thaik, and W. S. Colucci Pressure- and Volume-Induced Left Ventricular Hypertrophies Are Associated With Distinct Myocyte Phenotypes and Differential Induction of Peptide Growth Factor mRNAs Circulation, November 1, 1995; 92(9): 2385 - 2390. [Abstract] [Full Text]

				A. Nicoletti, D. Heudes, N. Hinglais, M.-D. Appay, M. Philippe, C. Sassy-Prigent, J. Bariety, and J.-B. Michel Left Ventricular Fibrosis in Renovascular Hypertensive Rats : Effect of Losartan and Spironolactone Hypertension, July 1, 1995; 26(1): 101 - 111. [Abstract] [Full Text]